113 related articles for article (PubMed ID: 3526500)
1. The use of an extended baseline period in the evaluation of treatment in a longitudinal Duchenne muscular dystrophy trial.
Madsen KS; Miller JP; Province MA
Stat Med; 1986; 5(3):231-41. PubMed ID: 3526500
[TBL] [Abstract][Full Text] [Related]
2. Clinical investigation in Duchenne muscular dystrophy: IV. Double-blind controlled trial of leucine.
Mendell JR; Griggs RC; Moxley RT; Fenichel GM; Brooke MH; Miller JP; Province MA; Dodson WE
Muscle Nerve; 1984 Sep; 7(7):535-41. PubMed ID: 6399927
[TBL] [Abstract][Full Text] [Related]
3. A trial of flunarizine in the treatment of Duchenne muscular dystrophy.
Dick DJ; Gardner-Medwin D; Gates PG; Gibson M; Simpson JM; Walls TJ
Muscle Nerve; 1986 May; 9(4):349-54. PubMed ID: 3520308
[TBL] [Abstract][Full Text] [Related]
4. Therapeutic trials on progressive muscular dystrophy.
Satoyoshi E
Intern Med; 1992 Jul; 31(7):841-6. PubMed ID: 1450492
[TBL] [Abstract][Full Text] [Related]
5. Intellectual function in Duchenne muscular dystrophy: the influence of penicillamine.
Buchanan DC; Roelofs RI; White DK; Saavedra de Arango G
Arch Phys Med Rehabil; 1981 Dec; 62(12):623-5. PubMed ID: 7032457
[TBL] [Abstract][Full Text] [Related]
6. Clinical investigation of Duchenne muscular dystrophy. Interesting results in a trial of prednisone.
Brooke MH; Fenichel GM; Griggs RC; Mendell JR; Moxley RT; Miller JP; Kaiser KK; Florence JM; Pandya S; Signore L
Arch Neurol; 1987 Aug; 44(8):812-7. PubMed ID: 3632393
[TBL] [Abstract][Full Text] [Related]
7. Chronic allopurinol and adenine therapy in Duchenne muscular dystrophy: effects on muscle function, nucleotide degradation, and muscle ATP and ADP content.
Bertorini TE; Palmieri GM; Griffin J; Chesney C; Pifer D; Verling L; Airozo D; Fox IH
Neurology; 1985 Jan; 35(1):61-5. PubMed ID: 3880875
[TBL] [Abstract][Full Text] [Related]
8. A trial of selenium and vitamin E in boys with muscular dystrophy.
Gamstorp I; Gustavson KH; Hellström O; Nordgren B
J Child Neurol; 1986 Jul; 1(3):211-4. PubMed ID: 3298399
[TBL] [Abstract][Full Text] [Related]
9. Therapeutic trial of isaxonine in Duchenne muscular dystrophy.
Heckmatt JZ; Hyde SA; Gabain A; Dubowitz V
Muscle Nerve; 1988 Aug; 11(8):836-47. PubMed ID: 3050510
[TBL] [Abstract][Full Text] [Related]
10. Low-dose prednisolone treatment in Duchenne and Becker muscular dystrophy.
Bäckman E; Henriksson KG
Neuromuscul Disord; 1995 May; 5(3):233-41. PubMed ID: 7633189
[TBL] [Abstract][Full Text] [Related]
11. Functional evaluation of Duchenne muscular dystrophy: proposal for a protocol.
Cornelio F; Dworzak F; Morandi L; Fedrizzi E; Balestrini MR; Gondoni L
Ital J Neurol Sci; 1982 Dec; 3(4):323-30. PubMed ID: 6762370
[TBL] [Abstract][Full Text] [Related]
12. [Therapeutic trial with allopurinol in progressive muscular dystrophy (author's transl)].
Pineda M; Fábregues I; Campistol J; Fernández Alvarez E; Alvarez M
An Esp Pediatr; 1982 Jan; 16(1):42-6. PubMed ID: 7044206
[TBL] [Abstract][Full Text] [Related]
13. Creatine monohydrate in muscular dystrophies: A double-blind, placebo-controlled clinical study.
Walter MC; Lochmüller H; Reilich P; Klopstock T; Huber R; Hartard M; Hennig M; Pongratz D; Müller-Felber W
Neurology; 2000 May; 54(9):1848-50. PubMed ID: 10802796
[TBL] [Abstract][Full Text] [Related]
14. [A therapeutic trial of mazindol versus placebo in Duchenne muscular dystrophy. A one-year follow-up study of 14 children].
Desnuelle C; Serratrice G; N'guyen VK; Richelme C; Pinsard N
Arch Fr Pediatr; 1989 Dec; 46(10):759-65. PubMed ID: 2697199
[TBL] [Abstract][Full Text] [Related]
15. Clinical investigation in Duchenne muscular dystrophy: penicillamine and vitamin E.
Fenichel GM; Brooke MH; Griggs RC; Mendell JR; Miller JP; Moxley RT; Park JH; Provine MA; Florence J; Kaiser KK
Muscle Nerve; 1988 Nov; 11(11):1164-8. PubMed ID: 3067086
[TBL] [Abstract][Full Text] [Related]
16. The progression of Duchenne muscular dystrophy: clinical trial of allopurinol therapy.
Stern LM; Fewings JD; Bretag AH; Ballard FJ; Tomas FM; Cooper DM; Goldblatt E
Neurology; 1981 Apr; 31(4):422-6. PubMed ID: 7012668
[TBL] [Abstract][Full Text] [Related]
17. Long-term benefit from prednisone therapy in Duchenne muscular dystrophy.
Fenichel GM; Florence JM; Pestronk A; Mendell JR; Moxley RT; Griggs RC; Brooke MH; Miller JP; Robison J; King W
Neurology; 1991 Dec; 41(12):1874-7. PubMed ID: 1745340
[TBL] [Abstract][Full Text] [Related]
18. Clinical trials of vasoactive and antiserotonin drugs in Duchenne muscular dystrophy.
Patten BM; Zeller RS
Ann Clin Res; 1983 Aug; 15(4):164-6. PubMed ID: 6360027
[TBL] [Abstract][Full Text] [Related]
19. Ineffectiveness of allopurinol in Duchenne muscular dystrophy.
Doriguzzi C; Bertolotto A; Ganzit GP; Mongini T; Palmucci L
Muscle Nerve; 1981; 4(2):176-8. PubMed ID: 7010155
[No Abstract] [Full Text] [Related]
20. Prednisone in Duchenne dystrophy. A randomized, controlled trial defining the time course and dose response. Clinical Investigation of Duchenne Dystrophy Group.
Griggs RC; Moxley RT; Mendell JR; Fenichel GM; Brooke MH; Pestronk A; Miller JP
Arch Neurol; 1991 Apr; 48(4):383-8. PubMed ID: 2012511
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
